<DOC>
<DOCNO>
EP-0001684
</DOCNO>
<TEXT>
<DATE>
19790502
</DATE>
<IPC-CLASSIFICATIONS>
C07K-5/00 C07K-1/113 C07K-14/435 C07K-5/107 C07K-14/655 C07K-1/00 C07K-5/10 A61K-38/07 C07K-5/087 C07K-14/575 A61K-38/22 <main>C07C-103/52</main> C07K-5/08 
</IPC-CLASSIFICATIONS>
<TITLE>
tetrapeptides, methods for their preparation and their use in analgesic compositions.
</TITLE>
<APPLICANT>
lilly co elius<sep>eli lilly and company<sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us<sep>eli lilly and company<sep>
</APPLICANT>
<INVENTOR>
frederickson robert curtis art<sep>shuman robert theodore<sep>smithwick edward lee jr<sep>frederickson, robert curtis arthur<sep>shuman, robert theodore<sep>smithwick, edward lee, jr<sep>frederickson, robert curtis arthur4225, marrison placeindianapolis indianaus<sep>shuman, robert theodore4155, rolling trailsgreenwood indianaus<sep>smithwick, edward lee, jr8250 shadow circleindianapolis indianaus<sep>frederickson, robert curtis arthur  <sep>shuman, robert theodore<sep>smithwick, edward lee, jr<sep>frederickson, robert curtis arthur4225, marrison placeindianapolis indianaus<sep>shuman, robert theodore4155, rolling trailsgreenwood indianaus<sep>smithwick, edward lee, jr8250 shadow circleindianapolis indianaus<sep>
</INVENTOR>
<ABSTRACT>
compounds of the general formula    and pharmaceutically acceptable non-toxic acid addition salts  thereof, in which l and d, when applicable, define the chirality;   r₁ and r₂ independently are hydrogen or c₁-c₃ primary  alkyl;   r₃ is c₁-c₄ primary or secondary alkyl or -ch₂ch₂-s-ch₃;   r₄ is hydrogen or c₁-c₃ primary alkyl;   r₅ is hydrogen or c₁-c₃ primary alkyl;   y is hydrogen or acetyl; and   z is   --nh₂, -ch₂oh, or -cn; subject to the limitation that  one of r₄ and r₅ is c₁-c₃ primary alkyl and the other is hydrogen;  are useful analgesic agents.  
</ABSTRACT>
</TEXT>
</DOC>
